HIV-1 envelope protein gp120 up regulates CCL5 production in astrocytes which can be circumvented by inhibitors of NF-κB pathway

Biochemical and Biophysical Research Communications

Volumn 414, Issue 1, 2011, Pages 112-117

  Shah, Ankit ^a   Singh, Dhirendra P ^b   Buch, Shilpa ^b   Kumar, Anil ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

CCL5; Gp120; NeuroAIDS; Neuroinflammation

Indexed keywords

GLYCOPROTEIN GP 120; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN INHIBITOR; RANTES; SC 514; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ASTROCYTES; CELLS, CULTURED; CHEMOKINE CCL5; HIV ENVELOPE PROTEIN GP120; HUMANS; NF-KAPPA B; RNA, SMALL INTERFERING; THIOPHENES; TRANSFECTION; UP-REGULATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80054069346     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.09.033     Document Type: Article

References (48)

1. Appay V., Rowland-Jones S.L. RANTES: a versatile and controversial chemokine. Trends Immunol. 2001, 22:83-87.
2. Conti P., DiGioacchino M. MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy Asthma Proc. 2001, 22:133-137.
3. Schall T.J. Biology of the RANTES/SIS cytokine family. Cytokine 1991, 3:165-183.
4. Fiala M., Lin J., Ringman J., Kermani-Arab V., Tsao G., Patel A., Lossinsky A.S., Graves M.C., Gustavson A., Sayre J., Sofroni E., Suarez T., Chiappelli F., Bernard G. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J. Alzheimers Dis. 2005, 7:221-232. discussion 255-262.
5. Reale M., Iarlori C., Thomas A., Gambi D., Perfetti B., Di Nicola M., Onofrj M. Peripheral cytokines profile in Parkinson's disease. Brain Behav. Immun. 2009, 23:55-63.
6. Denes A., Humphreys N., Lane T.E., Grencis R., Rothwell N. Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice. J. Neurosci. 2010, 30:10086-10095.
7. Kinter A., Catanzaro A., Monaco J., Ruiz M., Justement J., Moir S., Arthos J., Oliva A., Ehler L., Mizell S., Jackson R., Ostrowski M., Hoxie J., Offord R., Fauci A.S. CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction. Proc. Natl. Acad. Sci. USA 1998, 95:11880-11885.
8. Vago L., Nebuloni M., Bonetto S., Pellegrinelli A., Zerbi P., Ferri A., Lavri E., Capra M., Grassi M.P., Costanzi G. RANTES distribution and cellular localization in the brain of HIV-infected patients. Clin. Neuropathol. 2001, 20:139-145.
9. Kelder W., McArthur J.C., Nance-Sproson T., McClernon D., Griffin D.E. Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann. Neurol. 1998, 44:831-835.
10. Anthony I.C., Ramage S.N., Carnie F.W., Simmonds P., Bell J.E. Influence of HAART on HIV-related CNS disease and neuroinflammation. J. Neuropathol. Exp. Neurol. 2005, 64:529-536.
11. Sacktor N., McDermott M.P., Marder K., Schifitto G., Selnes O.A., McArthur J.C., Stern Y., Albert S., Palumbo D., Kieburtz K., De Marcaida J.A., Cohen B., Epstein L. HIV-associated cognitive impairment before and after the advent of combination therapy. J. Neurovirol. 2002, 8:136-142.
12. Becher B., Prat A., Antel J.P. Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia 2000, 29:293-304.
13. Chen Y., Swanson R.A. Astrocytes and brain injury. J. Cereb. Blood Flow Metab. 2003, 23:137-149.
14. Minagar A., Shapshak P., Fujimura R., Ownby R., Heyes M., Eisdorfer C. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J. Neurol. Sci. 2002, 202:13-23.
15. Li J., Bentsman G., Potash M.J., Volsky D.J. Human immunodeficiency virus type 1 efficiently binds to human fetal astrocytes and induces neuroinflammatory responses independent of infection. BMC Neurosci. 2007, 8:31.
16. Hesselgesser J., Taub D., Baskar P., Greenberg M., Hoxie J., Kolson D.L., Horuk R. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr. Biol. 1998, 8:595-598.
17. Kaul M., Ma Q., Medders K.E., Desai M.K., Lipton S.A. HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection. Cell Death Differ. 2007, 14:296-305.
18. Iskander S., Walsh K.A., Hammond R.R. Human CNS cultures exposed to HIV-1 gp120 reproduce dendritic injuries of HIV-1-associated dementia. J. Neuroinflammation 2004, 1:7.
19. Agrawal L., Louboutin J.P., Marusich E., Reyes B.A., Van Bockstaele E.J., Strayer D.S. Dopaminergic neurotoxicity of HIV-1 gp120: reactive oxygen species as signaling intermediates. Brain Res. 2010, 1306:116-130.
20. Ronaldson P.T., Bendayan R. HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein. Mol. Pharmacol. 2006, 70:1087-1098.
21. Viviani B., Gardoni F., Bartesaghi S., Corsini E., Facchi A., Galli C.L., Di Luca M., Marinovich M. Interleukin-1 beta released by gp120 drives neural death through tyrosine phosphorylation and trafficking of NMDA receptors. J. Biol. Chem. 2006, 281:30212-30222.
22. Shah A., Kumar A. HIV-1 gp120-mediated increases in IL-8 production in astrocytes are mediated through the NF-kappaB pathway and can be silenced by gp120-specific siRNA. J. Neuroinflammation 2010, 7:96.
23. Shah A., Verma A.S., Patel K.H., Noel R., Rivera-Amill V., Silverstein P.S., Chaudhary S., Bhat H.K., Stamatatos L., Singh D.P., Buch S., Kumar A. HIV-1 gp120 induces expression of IL-6 through a nuclear factor-kappa B-dependent mechanism: suppression by gp120 specific small interfering RNA. PLoS ONE 2011, 6:e21261.
24. Major E.O., Miller A.E., Mourrain P., Traub R.G., De Widt E., Sever J. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc. Natl. Acad. Sci. USA 1985, 82:1257-1261.
25. Haas J., Park E.C., Seed B. Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr. Biol. 1996, 6:315-324.
26. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
27. Alirezaei M., Watry D.D., Flynn C.F., Kiosses W.B., Masliah E., Williams B.R., Kaul M., Lipton S.A., Fox H.S. Human immunodeficiency virus-1/surface glycoprotein 120 induces apoptosis through RNA-activated protein kinase signaling in neurons. J. Neurosci. 2007, 27:11047-11055.
28. Hu S., Sheng W.S., Lokensgard J.R., Peterson P.K., Rock R.B. Preferential sensitivity of human dopaminergic neurons to gp120-induced oxidative damage. J. Neurovirol. 2009, 15:401-410.
29. Bansal A.K., Mactutus C.F., Nath A., Maragos W., Hauser K.F., Booze R.M. Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum. Brain Res. 2000, 879:42-49.
30. Zou S., El-Hage N., Podhaizer E.M., Knapp P.E., Hauser K.F. PTEN gene silencing prevents HIV-1 gp120(IIIB)-induced degeneration of striatal neurons. J. Neurovirol. 2011, 17:41-49.
31. Mucke L., Masliah E., Campbell I.L. Transgenic models to assess the neuropathogenic potential of HIV-1 proteins and cytokines. Curr. Top. Microbiol. Immunol. 1995, 202:187-205.
32. Louboutin J.P., Agrawal L., Reyes B.A., Van Bockstaele E.J., Strayer D.S. HIV-1 gp120-induced injury to the blood-brain barrier: role of metalloproteinases 2 and 9 and relationship to oxidative stress. J. Neuropathol. Exp. Neurol. 2010, 69:801-816.
33. Kanmogne G.D., Schall K., Leibhart J., Knipe B., Gendelman H.E., Persidsky Y. HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J. Cereb. Blood Flow Metab. 2007, 27:123-134.
34. Yang B., Akhter S., Chaudhuri A., Kanmogne G.D. HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood-brain barrier: modulatory effects of STAT1 signaling. Microvasc. Res. 2009, 77:212-219.
35. Kanmogne G.D., Primeaux C., Grammas P. HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: implications for the pathogenesis of HIV-associated dementia. J. Neuropathol. Exp. Neurol. 2005, 64:498-505.
36. Gordon C.J., Muesing M.A., Proudfoot A.E., Power C.A., Moore J.P., Trkola A. Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion. J. Virol. 1999, 73:684-694.
37. Trkola A., Gordon C., Matthews J., Maxwell E., Ketas T., Czaplewski L., Proudfoot A.E., Moore J.P. The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity. J. Virol. 1999, 73:6370-6379.
38. Dairaghi D.J., Soo K.S., Oldham E.R., Premack B.A., Kitamura T., Bacon K.B., Schall T.J. RANTES-induced T cell activation correlates with CD3 expression. J. Immunol. 1998, 160:426-433.
39. McDermott D.H., Beecroft M.J., Kleeberger C.A., Al-Sharif F.M., Ollier W.E., Zimmerman P.A., Boatin B.A., Leitman S.F., Detels R., Hajeer A.H., Murphy P.M. Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS 2000, 14:2671-2678.
40. Eugenin E.A., Osiecki K., Lopez L., Goldstein H., Calderon T.M., Berman J.W. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J. Neurosci. 2006, 26:1098-1106.
41. Fitting S., Zou S., Chen W., Vo P., Hauser K.F., Knapp P.E. Regional heterogeneity and diversity in cytokine and chemokine production by astroglia: differential responses to HIV-1 Tat, gp120, and morphine revealed by multiplex analysis. J. Proteome Res. 2010, 9:1795-1804.
42. Ubogu E.E., Callahan M.K., Tucky B.H., Ransohoff R.M. Determinants of CCL5-driven mononuclear cell migration across the blood-brain barrier. Implications for therapeutically modulating neuroinflammation. J. Neuroimmunology 2006, 179:132-144.
43. Meucci O., Fatatis A., Simen A.A., Bushell T.J., Gray P.W., Miller R.J. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. USA 1998, 95:14500-14505.
44. Fowler M.I., Yin K.Y., Humphries H.E., Heckels J.E., Christodoulides M. Comparison of the inflammatory responses of human meningeal cells following challenge with Neisseria lactamica and with Neisseria meningitidis. Infect. Immun. 2006, 74:6467-6478.
45. Samuelsson M., Fisher L., Iverfeldt K. Beta-Amyloid and interleukin-1beta induce persistent NF-kappaB activation in rat primary glial cells. Int. J. Mol. Med. 2005, 16:449-453.
46. Wilms H., Rosenstiel P., Sievers J., Deuschl G., Zecca L., Lucius R. Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease. FASEB J. 2003, 17:500-502.
47. Luo S.F., Fang R.Y., Hsieh H.L., Chi P.L., Lin C.C., Hsiao L.D., Wu C.C., Wang J.S., Yang C.M. Involvement of MAPKs and NF-kappaB in tumor necrosis factor alpha-induced vascular cell adhesion molecule 1 expression in human rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 2010, 62:105-116.
48. van Neerven S., Regen T., Wolf D., Nemes A., Johann S., Beyer C., Hanisch U.K., Mey J. Inflammatory chemokine release of astrocytes in vitro is reduced by all-trans retinoic acid. J. Neurochem. 2010, 114:1511-1526.